Teaming Up to Tackle Disease: This Week's Biopharma Collaborations
Published: Jul 07, 2021 By Alex Keown Collaborations are part of the life’s blood of clinical development as biopharma and life sciences companies partner and pool resources to develop novel therapies and treatments for a myriad of diseases. This morning, multiple companies announced clinical and strategic collaborations. PureTech Health to Harness BeiGene’s Checkpoint Inhibitor Boston-based PureTech Health plc and forged an alliance to assess the combination of BeiGene’s experimental checkpoint inhibitor tislelizumab with PureTech's LYT-200, an experimental monoclonal a...
Source: biospace.com